Long term use of oral bisphosphonates may double risk of esophageal cancer
Research: Oral bisphosphonates and risk of cancer of the esophagus, stomach and colorectum: Case-control analysis within a UK primary care cohortPeople who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published on bmj.com today.Oral bisphosphonates are a type of drug used to treat osteoporosis and other bone diseases and are the most commonly recommended treatment for such conditions.Case reports suggest an association between use of oral bisphosphonates for osteoporosis and increased risk of oesophageal cancer. But the evidence is limited, and no adequately large study with information on potential confounding factors and long follow-up has been published.So researchers from the University of Oxford's Cancer Epidemiology Unit and the Medicines and Healthcare products Regulatory Agency carried out a large-scale study to look into the possibility of an association.They analysed data from t
Long term use of oral bisphosphonates may double risk of esophageal cancer
People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published in ...
Thu 2 Sep 10 from PhysOrg
Long Term Use Of Oral Bisphosphonates May Double Risk Of Esophageal Cancer, Fri 3 Sep 10 from RedOrbit
Featured - Long term use of oral bisphosphonates may double risk of esophageal cancer, Fri 3 Sep 10 from Labspaces.net
Long term use of oral bisphosphonates may double risk of esophageal cancer, Thu 2 Sep 10 from e! Science News
Common bone drugs linked to esophageal cancer risk
LONDON (Reuters) - People who take a commonly used class of osteoporosis drugs called bisphosphonates for more than five years may be doubling their risk of developing cancer of the gullet or ...
Thu 2 Sep 10 from Reuters
Alternatives to Osteoporosis Drugs Bisphosphonates
Fri 3 Sep 10 from Emaxhealth
Researchers Take Another Look at Bisphosphonate-Cancer Link, Fri 3 Sep 10 from Emaxhealth
Osteoporosis Drugs May Be Linked to Cancer Risk
The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users ...
Thu 2 Sep 10 from WebMD
Bone drugs may raise risk of throat cancer
People who take many bone-strengthening drugs for several years may have a slightly higher risk of esophageal cancer, a new study says.British researchers analyzed the records of nearly 3,000 ...
Thu 2 Sep 10 from R&D Mag
- Pages: 1
Bookmark
